Johnson James A (CIK 0001225501)

Latest company ownership

ATHA - Athira Pharma, Inc.

Role: Director

Shares held

20,900

Last filed at

May 24, 2024

Confidence Score

50.0

2025Q4

Confidence Score History

2023Q1 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Mar 29, 2023	Mar 30, 2023	Athira Pharma, Inc.	Director	Buy	91.3	+5,000	100.00%	✗	$12K